Merzee
Product Images NDC 43386-371

8 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Merzee (NDC 43386-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
This forest plot chart displays relevant studies assessing the risk of breast cancer associated with combined oral contraceptives (COC). It compares effect estimates for 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' across several studies, plotting odds ratios, relative risks, and hazard ratios with confidence intervals along an effect estimate axis.*
FDA Label Image

Figure 2

Figure 2
A line graph showing Nortriptyline concentration (pg/mL) over time (hours) for Day 1 and Day 24. The plot compares drug concentration at various time points up to 60 hours, with two distinct curves representing measurements on Day 1 and Day 24.*
FDA Label Image

Figure 3

Figure 3
A pharmacokinetic line graph showing Ethinyl Estradiol concentration (pg/mL) over time (hours) for two time points, Day 1 and Day 24. Concentration peaks quickly then declines over 60 hours, with higher levels observed on Day 24 compared to Day 1.*
FDA Label Image

Figure 4

Figure 4
Diagram showing contraceptive methods categorized by effectiveness, arranged vertically with fewer pregnancies per 100 women per year at the top and more pregnancies at the bottom. Methods include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, behavioral methods, and no birth control.*
FDA Label Image

Figure 5

Figure 5
An illustrated dosing calendar for MERZEE 1 mg/20 mcg tablets showing a four-week pill pack with rows labeled Week 1 to Week 4 and columns for days Sunday through Saturday. Instructions indicate where to start for Sunday starters and Day-1 starters, guidance on placing the day label strip, and arrows directing to take pills from left to right each week.*
FDA Label Image

Merzee Carton Label (Merzee Carton)

Merzee Carton Label (Merzee Carton)
MERZEE 1 mg/20 mcg capsules packaging label by Lupin Pharmaceuticals, Inc. The label states the product contains norethindrone acetate and ethinyl estradiol capsules, and ferrous fumarate capsules. It provides 24 days of active therapy with 1 blister card of 28 soft gelatin capsules. The label includes dosage details, storage instructions, and contact information for adverse reactions.*
FDA Label Image

Structure-1 (Structure1)

Structure-1 (Structure1)
Chemical structure diagram of the active ingredient in MERZEE by Lupin Pharmaceuticals, Inc. The structure is a complex multi-ring steroid framework with specific functional groups including hydroxyl and alkyne groups shown.*
FDA Label Image

Structure-2 (Structure2)

Structure-2 (Structure2)
Chemical structure of MERZEE, showing the molecular framework and functional groups characteristic of the active ingredient as submitted by Lupin Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.